Displaying 181 - 190 of 335
Image
“I'm still here": Living with multiple myeloma for 12 years
Updated:
David Johnson, of BC, first diagnosed with the disease in 2012 in his early 50s, has experienced 2 relapses, 2 stem cell transplants, and participated in a clinical trial for CAR T-cell therapy. Dr. Anthony Reiman, medical oncologist in NB, talks about advances in MM treatment.
Myeloma
Image
Myelodysplastic Syndromes (MDS): A Conversation with Dr. Rena Buckstein
Updated:
Dr. Rena Buckstein from Odette Cancer Centre in Toronto shares the basics of myelodysplastic syndromes (MDS) diagnosis, treatment, and side effects.
Myelodysplastic syndromes
Image
Graft vs Host Disease (GvHD)
Updated:
Graft vs Host Disease, known as GvHD, is a side effect of a life saving procedure. People who undergo an allogeneic stem cell transplant - when a donor's stem cells are transplanted into the recipient - can experience either acute or chronic GvHD. In this podcast, listen to…
Treatment and side effects
Image
Causes of blood cancer - What we know - Innovation and Research Webcast Series 2023
Updated:
In this presentation, Dr. John Dick, one of Canada’s pioneering scientists in the field of “cancer stem cells”, will explain how his research into the causes of blood cancers holds the promise for improved treatments and quality of life for Canadians affected by blood cancers.
Diagnosis and tests, Leukemia, Research
Image
Artificial Intelligence and the Future of Blood Cancers webcast
Updated:
In this 2025 webcast, four scientists funded by the LLSC's AI Catalyst Grant talk about their work investigating how AI / machine learning can speed up discovery and detection of blood cancers in their research work. Moderated by Dr. Paul O'Connell, LLSC Research…
Research
Image
Understanding multiple myeloma
Updated:
Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.
Myeloma
Image
Immune effector cell-associated neurotoxicity syndrome (ICANS)
Updated:
Immune effector cell-associated neurotoxicity syndrome (ICANS) is a side effect that can happen after some forms of immunotherapy treatment. It may cause you to experience serious neurological symptoms.
Treatment and side effects
Image
Understanding polycythemia vera (PV): Diagnosis, treatments and follow-up care - myeloproliferative neoplasms (MPN) conference 2025
Updated:
In this 1-hour live webcast, Dr. Sonia Cerquozzi, hematologist at the Tom Baker Cancer Center and Peter Lougheed Centre in Calgary, reviews PV, a type of MPN - its diagnosis, treatment options and aspects of follow-up care.
Myeloproliferative neoplasms
Image
Diffuse Large B-Cell Lymphoma (DLBCL)
Updated:
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). DLBCL is fast-growing (aggressive) but treatable. It most often appears in older adults but can appear at any age.
Lymphoma
Image
Cutaneous T-cell Lymphoma (CTCL)
Updated:
Cutaneous T-cell lymphoma (CTCL) is a slow-growing (indolent) subtype of non-Hodgkin lymphoma (NHL). CTCL is rare, representing 4% of NHL cases. It starts in white blood cells (lymphocytes) that reside in the skin, called T-cells.
Lymphoma